Article info
Letters
Improvement of HbA1c during treatment with humanised anti-interleukin 6 receptor antibody, tocilizumab
- Correspondence to Dr Atsushi Ogata, Department of Respiratory Medicine, Allergy and Rheumatic Diseases, Osaka University Graduate School of Medicine, 2–2 Yamadaoka, Suita, Osaka 565–0871, Japan; ogata{at}imed3.med.osaka-u.ac.jp
Citation
Improvement of HbA1c during treatment with humanised anti-interleukin 6 receptor antibody, tocilizumab
Publication history
- Accepted September 19, 2010
- First published October 26, 2010.
Online issue publication
May 02, 2011
Article Versions
- Previous version (26 October 2010).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions